Over the last two decades, significant advances seen in technology and new methodologies have made proteomics an extremely powerful tool for protein scientists, biologists and clinical researchers. The introduction of the timsTOF platform coupled with the revolutionary PASEF® acquisition mode is not only breaking new boundaries in speed, sensitivity, selectivity and robustness, but also enabling 4D-Proteomics™ approaches, allowing scientists to routinely explore parts of the proteome not previously accessible at rapid scale.
The addition of the ion mobility dimension in the timsTOF instruments allows to reproducibly measure the Collisional Cross Section (CCS) values for all detected ions, and those can be used to further increase the system’s selectivity, enabling more and more reliable relative quantitation information from complex samples and short gradient analyses.
Join us for a workshop within the landscape of 4D-Proteomics™. What is it about? Where can it be used? How can clever computer designing and data acquisition facilitate increased proteomics depth?
Explore the 4th dimension with us during a lunch seminar before the actual SPS program begins.
Date: November 7, 2022
Time: 11:45 - 14:30 (CEST)
Venue: Elite Hotel Marina Tower
Address: Saltsjöqvarns Kaj 25, 131 71 Stockholm
11:45 - 12:10 Welcome and Lunch
Patrik Ek, Sales Manager, Bruker Nordic AB, Kista, Sweden
12:10 - 12:35 4D-Proteomics™ – what is it about?
Pierre-Olivier Schmit, Business Development Manager Proteomics, Bruker France SAS, Wissembourg, France
12:35 - 12:55 Bruker's solutions to support the complete proteomic ecosystem with PreOmics and PepSep
Lars Kristensen, Field Application Specialist, Bruker Nordic AB, Copenhagen, Denmark
12:55 - 13:35 PaSER – empowering the 4D-Proteomics™ ecosystem with a smart real-time search engine
Valeriia Kuzyk, Field Application Specialist, Bruker Nederland, Leiderdorp, Netherlands
13:35 - 13:55 Pushing the boundaries for robust and high-throughput single cell analysis with Whisper Flow technology powered by dia-PASEF
Nicolai Bache, Head of Applications, Evosep, Odense, Denmark
13:55 - 14:30 4D-Proteomics™ – addressing the challenges of clinical research
Pierre-Oliver Schmit, Business Development Manager Proteomics, Bruker France SAS, Wissembourg, France
For Research Use Only. Not for use in clinical diagnostic procedures.